The advertisement promotes Eliquis (apixaban) tablets, highlighting important safety information and warnings regarding the risks associated with premature discontinuation and potential complications.
Creative Information
| CID: | f152a6ae-eb88-4426-ac0d-4ae677c066f5 |
| CRID: | 89_219336 |
| Domain: | eliquis.com |
| Seat: | DInt |
| Size: | 300x600 |
| Bid: | $1.50 |
| Timestamp: | 11/18/2025, 8:38:54 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/18/2025, 10:31:01 PM | 4.67s | |
| adomain_analysis | success | 11/18/2025, 10:30:58 PM | 5.01s | |
| adomain_capture | success | 11/18/2025, 10:30:53 PM | 0.20s | |
| ad_render | success | 11/18/2025, 10:30:56 PM | 17.85s | |
| brand_mapping | success | 11/18/2025, 8:38:55 PM | 0.14s | |
Analysis Results
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1590.47 KB | ||||||||||||||||||||||
| Render Time: | 9.10 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 1590.47 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Raw Ad Markup
<span id='deepintent_wrapper_f9f428ad-ef5c-44e1-921b-bdbd3f721dbe' onclick=DeepIntentExecuteClicks('')><div style='display:inline-block;position:relative;height:600px'><script type='text/javascript'>document.addEventListener('DOMContentLoaded',function(){setTimeout(function(){new Image().src='https://useast-beacon.deepintent.com/vi?impid=816254c4-5275-3463-dc06-c2e04c1fbc80&spanlen='+ (document.getElementById('deepintent_wrapper_span_6-26c6-e9f4-3626-5317ce98ad16').innerHTML.length) + '&spanelemcnt=' + (document.getElementById('deepintent_wrapper_span_6-26c6-e9f4-3626-5317ce98ad16').getElementsByTagName('*').length);},3000)});</script><span id='deepintent_wrapper_span_6-26c6-e9f4-3626-5317ce98ad16'><ins class='dcmads' style='display:inline-block;width:300px;height:600px' data-dcm-placement='N2123577.3219362APEXDEALS/B32886535.422023594' data-dcm-rendering-mode='script' data-dcm-landing-page-escapes='2' data-dcm-click-tracker='https://useast-beacon.deepintent.com/click/816254c4-5275-3463-dc06-c2e04c1fbc80?ts=1762993753690&wp=1.5&loc=1&r=' data-dcm-https-only data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=${GDPR}' data-dcm-gdpr-consent='gdpr_consent=${GDPR_CONSENT_755}' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-resettable-device-id='' data-dcm-app-id='' data-dcm-param-dvs1='1' data-dcm-param-dvs2='${SOURCE_URL_ENC}' data-dcm-param-dvs3='214781' data-dcm-param-dvs4='816254c4-5275-3463-dc06-c2e04c1fbc80' data-dcm-param-dvs5='1' data-dcm-param-dvs6='103' data-dcm-param-dvs7='${BUNDLE_ID}' data-dcm-param-dvs8='219336' data-dcm-param-dvs9='${INSERTION_ORDER_ID}' data-dcm-param-dvs10='9056' data-dcm-param-dvs11='${UNIVERSAL_SITE_ID}' data-dcm-param-dvs12='${EXCHANGE_ID}' data-dcm-param-dvs13='1404354615' data-dcm-param-dvs14='1404354615' data-dcm-param-dvs15='${INVENTORY_SOURCE_EXTERNAL_ID}'> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins></span><script src="https://cdn.doubleverify.com/dvtp_src.js?ctx=20515845&cmp=DV973873&sid=deepintent&plc=deepintent_im_disp_js&adsrv=0&advid=3891363&ppid=118&dvtagver=6.1.src&aufilter1=IM&autt=1&auevent=816254c4-5275-3463-dc06-c2e04c1fbc80&aubndl=&pltfrm=10035&auip=143.112.144.129&DVPX_PP_AUCTION_UA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F142.0.0.0+Safari%2F537.36&turl=https%3A%2F%2Fwww.imdb.com%2Ftitle%2Ftt10294544%2F" type="text/javascript"></script><div id='aeopt' style='position:absolute;z-index:9010;background-color:#CCCCCCCC;top:0;right:0;border-radius:0 0 0 5px;'><div id='aeopti' style='display:block;'><a href='https://www.deepintent.com/adchoices?payload=XY1364ifzT8aSYbK7_0gcMcB-pNVFa2bqKTZBSW3-XQH7efaw%2C112%2Cdi_1b8e227bed1d4d5081ac1%2C1%2CU080147706%2C114%2C143.112.144.129%2C4%2Chc_f56d8697356ecff7a2610f56953bdc3e%2C7%2Ca98b58d75856a1a7bd6981b01526f0e24890e8c4%2C8%2C52d7888871da5fc3027fd3d71764cb699414535c37eb9754bd5965f38e105e0a%2C9%2CTH_62187014335%2C121%2C9E876FCACD5FE03D2E92642E0A169AE032607AAA691B797E6F6B5007AF3FB8BA%2C10%2CQ0NdUr1ZJx%2BsMpwo8tKWEl4f1WEOc0YEDz8%2FZ0nVK7c%3D%2C11%2CEDI_IFyq3vmUCsbGfv2Hsrc5nU%252FdTSf%252FVWzx1S3JGn%252BOJc0XxMuhZvmYFwr%252Feboqy6UL%2C14%2Cec27b8ee7597c62f8667f82a113fa43d' target='_blank' style='display:block;padding:1px 2px 1px 5px;'><img src='https://cdn.deepintent.com/adchoices/di-adchoices.png' alt='AdChoices' border='0' width='13' height='13' style='display:block;'></a></div></div></div></span><script type='text/javascript'>window.DeepIntentExecuteClicks=window.DeepIntentExecuteClicks||function(e){if(e)for(var n=e.split(','),t=0;t<n.length;t++)if(n[t])(new Image).src=n[t]};</script><noscript><img src='https://useast-beacon.deepintent.com/impression/816254c4-5275-3463-dc06-c2e04c1fbc80?ts=1762993753690&wp=1.5' height='0px' width='0px' style='display:none' referrerpolicy='no-referrer-when-downgrade'></noscript><script type="text/javascript">(function(){var r;try{r=window.location.ancestorOrigins[window.location.ancestorOrigins.length-1];}catch(e){}new Image().src='https://useast-beacon.deepintent.com/impression/816254c4-5275-3463-dc06-c2e04c1fbc80?ts=1762993753690&wp=1.5'+((typeof r==='string')?'&rf='+r:'');})();</script><iframe src='https://cdn.deepintent.com/syncpixel.html?_di_cfg=a' width='0' height='0' style='display:none;'></iframe>Creatives
